MLAB vs SHC
MLAB: Mesa Labs provides essential quality control instruments, consumables, and calibration services to protect patient safety and ensure product integrity in the life sciences and healthcare sectors. SHC: A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma companies.
Side-by-side fundamentals
| Metric | MLAB | SHC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $98.57 | $17.29 | |
| Market cap as of 2026-07-23 | $537M | $4.9B | |
| P/E as of 2026-07-23 | 80.05 | 41.86 | SHC lower |
| PEG as of 2026-07-23 | n/a | 3.82 | |
| Net margin as of 2026-07-23 | +2.7% | +9.9% | SHC higher |
| Gross margin as of 2026-07-23 | +63.5% | +55.3% | MLAB higher |
| Operating margin as of 2026-07-23 | +7.4% | +29.0% | SHC higher |
| ROE as of 2026-07-23 | +3.7% | +20.6% | SHC higher |
| ROA as of 2026-07-23 | +1.6% | +3.6% | SHC higher |
| Debt / equity as of 2026-07-23 | 0.81 | 3.59 | MLAB lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.4% | +7.4% | SHC higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | +5.1% | SHC higher |
| Dividend yield as of 2026-07-23 | +0.6% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.93 | 1.78 | |
| 1-year return as of 2026-07-22 close | +38.1% | +52.2% | SHC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.